Equities

Farmacosmo SpA

Farmacosmo SpA

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (EUR)0.49
  • Today's Change-0.009 / -1.80%
  • Shares traded112.48k
  • 1 Year change-25.98%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.076.851.41
Total Receivables, Net6.82105.71
Total Inventory7.334.732.08
Prepaid expenses0.150.080.06
Other current assets, total0.74----
Total current assets20229.26
Property, plant & equipment, net0.490.480.30
Goodwill, net11110.00
Intangibles, net4.825.111.10
Long term investments0.050.050.06
Note receivable - long term0.070.580.05
Other long term assets0----
Total assets363911
LIABILITIES
Accounts payable12158.01
Accrued expenses0.961.100.57
Notes payable/short-term debt000.24
Current portion long-term debt/capital leases1.491.18--
Other current liabilities, total0.742.160.16
Total current liabilities15198.98
Total long term debt5.200.690.38
Total debt6.691.870.62
Deferred income tax0.03----
Minority interest2.461.62--
Other liabilities, total0.700.600.44
Total liabilities23229.80
SHAREHOLDERS EQUITY
Common stock3.483.010.07
Additional paid-in capital1414--
Retained earnings (accumulated deficit)(4.25)0.380.90
Treasury stock - common(0.11)(0.25)--
Unrealized gain (loss)------
Other equity, total0----
Total equity13170.97
Total liabilities & shareholders' equity363911
Total common shares outstanding393833
Treasury shares - common primary issue0.050.110
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.